Ms Brenna O’Masta holds a Master of Public Health (MPH) in Epidemiology from the University of Washington, USA and a Bachelor of Science (BS) in Biochemistry from the University of Virginia, USA. While in graduate school, she worked as a data analyst for a genetic epidemiology research group at the Fred Hutchinson Cancer Research Center in Seattle, Washington, resulting in her thesis on the association between inflammation-related gene variants and the risk of colorectal cancer and interactions with non-steroidal anti-inflammatory drug use for pharmacogenetic application. She has also worked with the Washington State Department to develop a novel pneumococcal disease surveillance system using near real-time syndromic data feed from a newly formed health information exchange. After graduating, she worked as an epidemiological analyst at a life science and public health consulting company, where she led evidence-based projects for several U.S. Federal Government agencies including the Centers for Disease Control and Prevention. Through this role, she led a large coding and meta-analysis project that aimed to identify key risk factors for ADHD.
Brenna joined Cambridge Clinical Informatics in April 2015 where she intends to focus her skills in epidemiology, biostatistical modelling and database development to advance translational research using electronic health records. Brenna’s current work focuses on supporting Epic builds to enable research and understanding how data are recorded in Epic for rapid extraction – this work will support planned projects that aim to understand infections in hospitalised patients and assess a variety of disease risk factors.
Brenna left Cambridge Clinical Informatics in 2016.
Seufert BL, Poole EM, Whitton J, Xiao L, et al. IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis, 2013 34(1):79–85.
Kleinstein SE, Heath L, Makar KW, Poole EM, Seufert BL, et al. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes, Chromosomes and Cancer, 2013 52(5):437-449.
Makar KW, Poole E.M., Resler AJ, Seufert BL, et al. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control, 2013 24(12): 2059-2075.